Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Rose 42.2% in First Three Quarters of 2023

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 162.8 million yuan in the first three quarters of 2023, up 42.2% year-on-year.

Meanwhile, the company posted 720 million yuan in revenue, up 22.5% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 363.5 million yuan in total liabilities, with a liability-to-asset ratio of 9.6%.